External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

AACR 2023

April 14 - April 19

Orlando, USA

aacr-2023

Add to calendar

Medical Materials

Agenda

Coming soon

12:45 PM

Duration 15mins Chapin Theater

IMbrave050: Phase 3 study of adjuvant atezolizumab + bevacizumab versus active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence following resection or ablation

Pierce Chow, Minshan Chen, Ann-Lii Cheng, Ahmed Kaseb, Masatoshi Kudo, Han Chu Lee, Adam Yopp, Jian Zhou, Lu Wang, Xiaoyu Wen, Jeong Heo, Won Young Tak, Shinichiro Nakamura, Kazushi Numatta, Thomas Uguen, David Hsiehchen, Edward Cha, Stephen P. Hack, Qinshu Lian, Jessica Spahn, Chun Wu, Shukui Qin

Oncology | Gastrointestinal Cancer

Add to calendar

02:30 PM

Duration 5mins Orlando, USA

Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockade

Namrata Patil

Oncology | Lung Cancer

Add to calendar

02:52 PM

Duration 15mins Valencia A, Convention Center

Ovarian Cancer Tumor Microenvironment and Atezolizumab Clinical Activity: IMagyn050 sub-study

Venkatesh Krishnan, Ching-Wei Chang, Habib Hamidi, Michael Bookman, Charles Landen, Tashanna Myers, Hiroaki Kajiyama, Sakari Hietanen, Lyndsay Willmott, Premal Thaker, Cagatay Taskiran, Jalid Sehouli, Victor Khor, Yvonne G. Lin Sandro Pignata, Kathleen Moore, Luciana Molinero

Oncology | Ovarian Cancer

Add to calendar

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.